Solid Biosciences Inc. Uncategorized Contracts & Agreements
12 Contracts & Agreements
- Form of Parent Support Agreement (Filed With SEC on September 30, 2022)
- Executive Chair Agreement, effective January 1, 2022, by and between Solid Biosciences Inc. and Ian F. Smith (Filed With SEC on March 14, 2022)
- Investor Agreement, dated as of October 22, 2020, by and between the Company and Ultragenyx Pharmaceutical Inc (Filed With SEC on November 5, 2020)
- Description of the Companys Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 12, 2020)
- Plan of Conversion, dated January 25, 2018 (Filed With SEC on March 29, 2018)
- Amendment to Offer Letter, dated November 17, 2017, by and between Solid Biosciences, LLC and Jennifer Ziolkowski (Filed With SEC on January 16, 2018)
- Offer Letter, dated as of April 17, 2017, by and between Solid Biosciences, LLC and Jennifer Ziolkowski (Filed With SEC on January 16, 2018)
- Form of Plan of Conversion (Filed With SEC on January 16, 2018)
- Offer Letter, dated as of November 6, 2015, by and between Solid Biosciences, LLC and Alvaro Amorrortu (Filed With SEC on December 29, 2017)
- Offer Letter, dated as of November 17, 2015, by and between Solid GT, LLC and Jorge A. Quiroz, M.D (Filed With SEC on December 29, 2017)
- Form of Certificate of Conversion of Solid Biosciences, LLC (Filed With SEC on December 29, 2017)
- Form of Plan of Conversion (Filed With SEC on December 29, 2017)
